NCT01942122 - DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 28, 2021

Study Completion Date

April 30, 2021

Conditions

EndometriomaVisual Analogue Pain Scale: Moderate or Severe Pain

Interventions

DRUG

DLBS1442 100

Study treatment will be DLBS1442 capsules at a dose of 3x100 mg daily. DLBS1442 will be taken every day for 8 weeks (2 menstrual cycles).

DRUG

Mefenamic acid

Control will be mefenamic acid 500 mg tablets, administered 3 times daily for 5 days during the menstrual period, i.e. day 1st to day 5th of the menstrual period. The drug will be given within the 8 weeks of study period (2 menstrual cycles).

DRUG

DLBS1442 200

Study treatment will be DLBS1442 capsules at a dose of 3x200 mg daily. DLBS1442 will be taken every day for 8 weeks (2 menstrual cycles).

Trial Locations (3)

10430

Yasmin Clinic, Dr. Cipto Mangunkusumo Hospital (Kencana), Jakarta Pusat

Unknown

Department of Obstetrics and Gynecology, RSUP Persahabatan, Jakarta Pusat

Department of Obstetrics and Gynecology RSUP Fatmawati, Jakarta